Rashed Dewan

Director of Finance/CFO at PROFOUND MEDICAL CORP.

Net worth: 190 688 $ as of 29/04/2024

56 year

Health Technology

Consumer Services

Rashed Dewan active positions

Companies	Position	Start	End
PROFOUND MEDICAL CORP.	Director of Finance/CFO	02/03/2022	-
	Comptroller/Controller/Auditor	18/05/2021	02/03/2022
	Human Resources Officer	-	02/03/2022
	Corporate Officer/Principal	02/05/2018	18/05/2021

Companies	Position	Start	End
Profound Medical, Inc. Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.	Comptroller/Controller/Auditor	05/07/2015	-

University of Southern California

Undergraduate Degree

International

Canada	3
United States	2

Operational

Comptroller/Controller/Auditor	2
Director of Finance/CFO	1
Human Resources Officer	1

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
PROFOUND MEDICAL CORP.	Health Technology

Private companies	1
Profound Medical, Inc. Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.	Health Technology

Private companies

Health Technology